Oct 062020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– NETHERLANDS, Amsterdam –  Neogene Therapeutics, Inc., a pre-clinical stage biotechnology company pioneering a new class of fully personalized neo-antigen T cell therapies to treat cancer, today announced the appointment of Dr. Franz Humer, Ph.D., as Executive Chairman of the Board of Directors. A world-renowned pharmaceutical industry trailblazer, Dr. Humer ...

Neogene Therapeutics welcomes Dr. Franz Humer as Executive Chairman alongside a slate of women in VC onto Board of Directors

Neogene Therapeutics welcomes Dr. Franz Humer as Executive Chairman alongside a slate of women in VC onto Board of Directors

From:: Neogene Therapeutics welcomes Dr. Franz Humer as Executive Chairman alongside a slate of women in VC onto Board of Directors

Sorry, the comment form is closed at this time.